CD8A and systemic sclerosis: Anti-Scl-70-positive patients demonstrated elevated CD8<sup>+</sup> effector T cells, whereas anti-centromere-positive patients showed increased ThGM-CSF cells in the skin.<h4>Conclusions</h4>These findings highlight the potential role of distinct immune subsets for disease progression and tissue-specific fibrosis in SSc.